Worldwide Clinical Trials Wins 2021 CRO Leadership Awards for Eighth Consecutive Year

Pharma and Biotech Organizations Laud Company’s Capabilities, Compatibility, Expertise, Reliability and Quality

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–#BioTech—Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research organization (CRO), today announced that it was honored with five 2021 CRO Leadership Awards, presented by Clinical Leader and Life Science Leader.

The CRO Leadership Awards recognize top CROs based on direct feedback from decision-makers at pharmaceutical companies of all sizes that have outsourced clinical trials over the last 18 months. Award selection is based on primary market research conducted by the Industry Standard Research (ISR) annual CRO Quality Benchmarking survey, which evaluated 60 CROs across more than 20 performance metrics and five core categories.

“ISR’s stringent screening processes ensures that only highly qualified industry decision-makers participate in our CRO benchmarking market research,” said Kevin Olson, CEO of ISR. “This is paramount as we ask the research participants to provide experiential, not perceptual, feedback on their involvement with contract suppliers over the past 18 months. The data enables users of ISR’s market research to make confident business decisions based on the experiences of their industry peers.”

This is the eighth consecutive year that customers have rated Worldwide as an exemplary performer across all five core categories:

• Capabilities (Overall, Big Pharma, Small Pharma)
• Compatibility (Overall, Big Pharma, Small Pharma)
• Expertise (Overall, Big Pharma, Small Pharma)
• Reliability (Overall, Small Pharma)
• Quality (Overall, Big Pharma, Small Pharma)

“The CRO Leadership Award winners have proven themselves to be the top service providers in each category,” says Ed Miseta, chief editor for Clinical Leader. “I congratulate all of them for the work ethic they exhibit in consistently meeting the needs of their drug development clients.”

Worldwide continues to invest in the scientific, medical and operations expertise needed to meet the demand of small to midsized biotech and pharmaceutical organizations seeking support for complex studies.

“The CRO Leadership Awards reflect our customers’ appreciation for our team’s commitment to our vision of being the world’s best global, midsized CRO, and I could not be prouder of their recognition,” said Peter Benton, president and chief operating officer, Worldwide Clinical Trials. “Our outstanding reputation, particularly among small and midsized biopharma organizations, is testament to our proven track record for delivering the quality, customer service, and scientific and medical expertise their trial deserves.”

Request your complimentary executive summary of ISR’s 2021 CRO Quality Benchmarking report today.

About Worldwide Clinical Trials

Worldwide Clinical Trials employs 2,000+ professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia, and Asia-Pacific. Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval, and real-world evidence, we provide world-class, full-service drug development services.

With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, general medicine, oncology, and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO. For more information, visit www.worldwide.com.

Contacts

Media:
Worldwide Clinical Trials

Sherri Stuart

VP, Global Corporate Communications

[email protected]